• Explore /
  • Poster
  • / Cost-effectiveness analysis of stereotactic ablative radiotherapy in patients with oligometastatic cancer.

Cost-effectiveness analysis of stereotactic ablative radiotherapy in patients with oligometastatic cancer.

Abstract Poster

Authors

null

Abhishek Kumar

UC San Diego Health System, La Jolla, CA

Abhishek Kumar , Christopher Andrew Straka , Lucas Vitzthum , Daniel R Cherry , Patrick T Courtney , Paul Riviere , James Don Murphy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Value/Cost of Care

Citation

J Clin Oncol 38: 2020 (suppl; abstr 7085)

DOI

10.1200/JCO.2020.38.15_suppl.7085

Abstract #

7085

Poster Bd #

357

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Breakthrough

Second chance for cure: Stereotactic ablative radiotherapy in oligometastatic disease.

Second chance for cure: Stereotactic ablative radiotherapy in oligometastatic disease.

First Author: Nidal Salim

First Author: Teerada Siripoon

First Author: Young Suk Suk Kwon

First Author: Giulio Francolini